Continue Reading
Full article on Financial Times
Moderna is most shorted stock in S&P 500 as Americans skip jabs
Market Intelligence Analysis
AI-Powered 82% GROQ-LLAMA-3.1-8B-INSTANT
Why This Matters
Moderna, the COVID-19 vaccine manufacturer, has become the most shorted stock in the S&P 500 as Americans' sentiment towards vaccines has shifted, leading to a decline in the company's stock price since the pandemic.
Market Context
Market impact analysis based on bearish sentiment with 82% confidence.
Sentiment
Bearish
AI Confidence
82%
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Maker of Covid-19 shots has slumped since pandemic as people turn against vaccines
AI Breakdown
Summary
Moderna, the COVID-19 vaccine manufacturer, has become the most shorted stock in the S&P 500 as Americans' sentiment towards vaccines has shifted, leading to a decline in the company's stock price since the pandemic.
Market Context
Market impact analysis based on bearish sentiment with 82% confidence.
Original article published by
Financial Times
on November 23, 2025.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.